Xeltis’ restorative heart valve replacement approach will be in focus on March 6 at CRT2018, one of the world’s leading interventional cardiology conferences, in Washington D.C.
Two oral presentations during the 10:21am EST session on heart valve innovations will focus on the progression of Xeltis’ restorative aortic and pulmonary valve trial programs.
Patrick Serruys, Professor of Cardiology, Imperial College London (UK) and Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will respectively outline the promising potential of Xeltis’ restorative pulmonary and aortic valves. Their oral presentations will include preclinical trial outcomes of both devices and an overview on the ongoing pulmonary valve clinical research.
For more information on the latest pulmonary valve Xplore-2 clinical trial, which is currently enrolling pediatric patients in U.S. centers, please visit xplore2trial.com.
Click here to view the CRT2018 program details.